{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:07:08Z","timestamp":1790266028960,"version":"4.1.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"abstract":"\n Importance<\/jats:title>\n Colorectal cancer is the third most common and deadly cancer among women worldwide. Although ovarian metastases from colon cancer are relatively uncommon, they remain clinically significant due to their association with poor prognosis and the longstanding suspicion that the ovaries may function as a chemotherapy-resistant sanctuary site. This review examines the evidence for this phenomenon and potential role of surgical resection of metastatic disease.<\/jats:p>\n <\/jats:sec>\n \n Observations<\/jats:title>\n Twenty-four retrospective studies comprising 2705 patients with ovarian metastases from colorectal cancer were evaluated. Ovarian metastases demonstrated lower objective chemotherapy response rates than extraovarian metastases, had substantially lower mean shrinkage, and frequently exhibited discordant growth during treatment. The most favorable outcomes associated with improved survival were observed in patients who had complete surgical resection of ovarian metastases and microscopically negative margins.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Collectively, the literature supports the ovary functioning as a relative sanctuary site in metastatic colorectal cancer, suggesting that systemic therapy alone should not be regarded as adequate. Instead, systemic therapy assumes a complementary role in reducing overall tumor burden and improving candidacy for resection. Therefore, optimal management should aim for clearance of all macroscopic disease, with negative surgical margins pursued when feasible. Metastasectomy should be performed within the context of comprehensive disease control, including resection of the primary tumor.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2026.3634","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:30:32Z","timestamp":1790263832000},"source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy and Surgical Outcomes for Ovarian Metastases From Colorectal Cancer"],"prefix":"10.1001","author":[{"given":"James B. E.","family":"Weil","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"3","key":"crv260003r1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"crv260003r2","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults.","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"issue":"7","key":"crv260003r3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","article-title":"Changes in colorectal cancer incidence in seven high-income countries: a population-based study.","volume":"4","author":"Araghi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"crv260003r4","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9841295","article-title":"Increasing incidence of colorectal cancer in young adults.","volume":"2019","author":"Loomans-Kropp","year":"2019","journal-title":"J Cancer Epidemiol"},{"issue":"10","key":"crv260003r5","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1136\/gutjnl-2018-317592","article-title":"Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.","volume":"68","author":"Vuik","year":"2019","journal-title":"Gut"},{"issue":"11","key":"crv260003r6","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1002\/ijc.30382","article-title":"A global view on cancer incidence and national levels of the human development index.","volume":"139","author":"Fidler","year":"2016","journal-title":"Int J Cancer"},{"issue":"8","key":"crv260003r7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"crv260003r8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality.","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"issue":"1","key":"crv260003r9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer.","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"crv260003r10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ygyno.2003.12.039","article-title":"Incidence of metastasis to the ovaries from nongenital tract primary tumors.","volume":"93","author":"Moore","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"crv260003r11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000449348","article-title":"Colorectal liver metastases: a critical review of state of the art.","volume":"6","author":"Jones","year":"2016","journal-title":"Liver Cancer"},{"issue":"4","key":"crv260003r12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3816\/CCC.2004.n.002","article-title":"Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy.","volume":"3","author":"Hanna","year":"2004","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"crv260003r13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF01889071","article-title":"CT findings in metastatic ovarian tumors from gastrointestinal tract neoplasms (Krukenberg tumors).","volume":"13","author":"Mata","year":"1988","journal-title":"Gastrointest Radiol"},{"issue":"1","key":"crv260003r14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tjog.2015.02.009","article-title":"Difficulty in diagnosis and different prognoses between colorectal cancer with ovarian metastasis and advanced ovarian cancer: An empirical study of different surgical adoptions.","volume":"56","author":"Lee","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"crv260003r15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ygyno.2003.12.025","article-title":"Pseudo-Meigs\u2019 syndrome secondary to isolated colorectal metastasis to ovary: a case report and review of the literature.","volume":"93","author":"Feldman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"crv260003r16","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.2147\/CMAR.S254876","article-title":"Impact of ovarian metastatectomy on survival outcome of colorectal cancer patients with ovarian metastasis: a retrospective study.","volume":"12","author":"Li","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"1","key":"crv260003r17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.rct.0000149958.86165.ca","article-title":"Computed tomography findings of ovarian metastases from colon cancer: comparison with primary malignant ovarian tumors.","volume":"29","author":"Choi","year":"2005","journal-title":"J Comput Assist Tomogr"},{"issue":"9","key":"crv260003r18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s10147-020-01717-7","article-title":"Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance.","volume":"25","author":"Kato","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"crv260003r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108823","article-title":"Differentiation between ovarian metastasis from colorectal carcinoma and primary ovarian carcinoma: evaluation of tumour markers and \u201cmille-feuille sign\u201d on computed tomography\/magnetic resonance imaging.","volume":"124","author":"Kurokawa","year":"2020","journal-title":"Eur J Radiol"},{"issue":"2","key":"crv260003r20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.","volume":"98","author":"Ayhan","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"12","key":"crv260003r21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.ejso.2008.03.010","article-title":"The differential response to chemotherapy of ovarian metastases from colorectal carcinoma.","volume":"34","author":"Go\u00e9r\u00e9","year":"2008","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"crv260003r22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ygyno.2007.02.025","article-title":"The role of cytoreductive surgery for colon cancer metastatic to the ovary.","volume":"105","author":"McCormick","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"2","key":"crv260003r23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/modpathol.2010.204","article-title":"Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.","volume":"24","author":"Okamoto","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"crv260003r24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1309\/G56H-97A2-JFMT-CD5N","article-title":"Ovarian metastases from colorectal carcinoma: clinicopathologic profile, immunophenotype, and karyotype analysis.","volume":"114","author":"Dionigi","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"crv260003r25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12253-016-0040-2","article-title":"PAX2, PAX8 and CDX2 expression in metastatic mucinous, primary ovarian mucinous and seromucinous tumors and review of the literature.","volume":"22","author":"Ates Ozdemir","year":"2016","journal-title":"Pathol Oncol Res"},{"key":"crv260003r26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2407-14-323","article-title":"Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.","volume":"14","author":"Buchler","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"crv260003r27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12885-016-2734-y","article-title":"Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.","volume":"16","author":"Botrel","year":"2016","journal-title":"BMC Cancer"},{"issue":"23","key":"crv260003r28","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial.","volume":"317","author":"Venook","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"crv260003r29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S1470-2045(16)30269-8","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial.","volume":"17","author":"Stintzing","year":"2016","journal-title":"Lancet Oncol"},{"issue":"12","key":"crv260003r30","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1007\/s00384-021-04012-7","article-title":"Ovarian metastases from colorectal cancer in young women: a systematic review of the literature.","volume":"36","author":"van der Meer","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"crv260003r31","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-06-2659","article-title":"The biology of metastasis to a sanctuary site.","volume":"13","author":"Palmieri","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9","key":"crv260003r32","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/cncr.10492","article-title":"TNM residual tumor classification revisited.","volume":"94","author":"Wittekind","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"crv260003r33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"8","key":"crv260003r35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/ijgc-2020-002328","article-title":"Colorectal cancer ovarian metastases.","volume":"31","author":"Thornblade","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"crv260003r36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00423-023-03060-7","article-title":"Aggressive surgical intervention may improve prognosis in patients with ovarian metastasis from colorectal cancer.","volume":"408","author":"Nomura","year":"2023","journal-title":"Langenbecks Arch Surg"},{"issue":"7","key":"crv260003r37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1634\/theoncologist.2019-0282","article-title":"Clinicopathologic characteristics and impact of oophorectomy for ovarian metastases from colorectal cancer.","volume":"25","author":"Ursem","year":"2020","journal-title":"Oncologist"},{"issue":"10","key":"crv260003r38","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s10147-020-01730-w","article-title":"Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience.","volume":"25","author":"Zhou","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"9","key":"crv260003r39","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/ans.14930","article-title":"Complete resection of colorectal cancer with ovarian metastases combined with chemotherapy is associated with improved survival.","volume":"89","author":"Al-Busaidi","year":"2019","journal-title":"ANZ J Surg"},{"issue":"6","key":"crv260003r40","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/jso.21675","article-title":"Significance of the resection of ovarian metastasis from colorectal cancers.","volume":"102","author":"Fujiwara","year":"2010","journal-title":"J Surg Oncol"},{"issue":"7","key":"crv260003r41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jso.21382","article-title":"Role of surgery in the treatment of ovarian metastases from colorectal cancer.","volume":"100","author":"Chung","year":"2009","journal-title":"J Surg Oncol"},{"issue":"4","key":"crv260003r42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000489665","article-title":"Retrospective analyses of systemic chemotherapy and cytoreductive surgery for patients with ovarian metastases from colorectal cancer: a single-center experience.","volume":"95","author":"Sekine","year":"2018","journal-title":"Oncology"},{"issue":"2","key":"crv260003r43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00280-009-1150-2","article-title":"Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.","volume":"66","author":"Lee","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"crv260003r44","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1002\/cncr.30424","article-title":"Clinical and genetic determinants of ovarian metastases from colorectal cancer.","volume":"123","author":"Ganesh","year":"2017","journal-title":"Cancer"},{"issue":"7","key":"crv260003r45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/cbr.2020.4013","article-title":"Retrospective analyses of complete resection combined with systemic chemotherapy and targeted therapy for patients with ovarian metastases from colorectal cancer.","volume":"37","author":"Tong","year":"2022","journal-title":"Cancer Biother Radiopharm"},{"issue":"6","key":"crv260003r46","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00384-021-03842-9","article-title":"Clinical characteristics and prognostic factors of colorectal cancer patients with ovarian metastasis: a multicenter retrospective study.","volume":"36","author":"Li","year":"2021","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"crv260003r47","first-page":"191","article-title":"Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary.","volume":"11","author":"Garrett","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"crv260003r48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/CMAR.S285451","article-title":"Significance of surgery in the treatment of colorectal cancer ovarian metastases: a retrospective case matching study.","volume":"13","author":"Xu","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"1","key":"crv260003r49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12957-021-02305-3","article-title":"Prognostic factors for ovarian metastases in colorectal cancer patients.","volume":"19","author":"Chen","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"1","key":"crv260003r50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12957-016-1087-y","article-title":"Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.","volume":"15","author":"Xu","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"3","key":"crv260003r51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1096-9098(200011)75:3<186::AID-JSO6>3.0.CO;2-S","article-title":"Outcome after ovarian\/adnexal metastectomy in metastatic colorectal carcinoma.","volume":"75","author":"Rayson","year":"2000","journal-title":"J Surg Oncol"},{"issue":"1","key":"crv260003r52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/bjc.1995.18","article-title":"Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment.","volume":"71","author":"Taylor","year":"1995","journal-title":"Br J Cancer"},{"issue":"1","key":"crv260003r53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12957-022-02498-1","article-title":"Decision-making in postoperative chemotherapy for ovarian metastasis from colorectal cancer: a retrospective single-center study.","volume":"20","author":"Hamasaki","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"4","key":"crv260003r54","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13193-017-0667-9","article-title":"Ovarian metastases of colorectal origin: treatment patterns and factors affecting outcomes.","volume":"8","author":"Kammar","year":"2017","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"crv260003r55","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/diagnostics14010006","article-title":"Prediction of chemotherapy efficacy in patients with colorectal cancer ovarian metastases: a preliminary study using contrast-enhanced computed-tomography\u2013based radiomics.","volume":"14","author":"Yu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"crv260003r34","unstructured":"Gierisch? JM, Beadles? C, Shapiro? A, . Health disparities in quality indicators of healthcare among adults with mental illness. Accessed February 8, 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK299087\/"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2854531\/jamaoncology_weil_2026_rv_260003_1789768710.70389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:30:36Z","timestamp":1790263836000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2854531"}},"subtitle":["A Narrative Review"],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2026.3634","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}